Chitose and Fujifilm Biosciences sign biopharma manufacturing alliance
The deal will see the companies combine their respective work on CHO-MK cells and GMP-manufactured culture media.
List view / Grid view
The deal will see the companies combine their respective work on CHO-MK cells and GMP-manufactured culture media.
The impurities research illustrates an approach that could offer a simpler and more flexible downstream purification process.
17 December 2025 | By Particle Measuring Systems
Join this webinar as we examine the main personnel-related factors that could lead to particle/microbial contamination risks of the product and outline practical measures that can mitigate these risks.
UK biotech commits to scale up of 228Th extraction and a long-term supply agreement to facilitate production of thousands of doses of 212Pb for cancer therapies annually.
The move consolidates Ireland’s two leading producers of the antibiotics.
15 December 2025 | By Mettler Toledo
Join this webinar to gain insight about the changes to United States Pharmacopeia (USP) General Chapters 41 and 1251 on balance requirements for quality control.
Here, Hexagon outlines a four-step plan to address silos and scale-up challenges, drawing on the experience of leading pharma firms like Pfizer.
Announcement of Eli Lilly and Company's fourth new US manufacturing plant is expected within the next few weeks.
The Melbourne site adds Australia to a select group of nations with advanced cell-based influenza vaccine capabilities.
CDMOs weigh up how to meet manufacturing demands across oral solid doses, monoclonal antibodies, ADCs and beyond.
Nippon Muki demonstrates the performance advantages of its innovative HEPA filter for the sterilisation of injectable containers in pharmaceutical manufacturing.
New trade deal to “ignite economic growth” and help boost the UK’s position as a superpower in life sciences.
2 December 2025 | By Emerson
Is operational complexity limiting your performance? Discover how autonomous technologies are reducing risk and improving quality in pharma organisations.
EPR Issue 4 includes articles on manufacturing, AI/ML, vaccine development, biologics and more.
New BSI standard PAS 2090 could reshape how the pharmaceutical industry reports and minimises its environmental footprint.